EUA
MidaSpot COVID-19 Antibody Combo Detection Kit
FDA Emergency Use Authorization · Nirmidas Biotech, Inc. · Nov 2, 2021
Key facts
| Product | MidaSpot COVID-19 Antibody Combo Detection Kit |
|---|---|
| Company | Nirmidas Biotech, Inc. |
| Product type | IgM and IgG, lateral flow, Fingerstick Whole Blood |
| Date | Nov 2, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: